Cellular Intelligence, a rapidly emerging biotech firm previously known as Somite AI, has secured global rights to a pioneering clinical-stage…
Read More

Cellular Intelligence, a rapidly emerging biotech firm previously known as Somite AI, has secured global rights to a pioneering clinical-stage…
Read More
In a significant move poised to reshape the landscape of Parkinson’s disease treatment and the broader cell therapy sector, Cellular…
Read More
Cellular Intelligence, a burgeoning biotech startup, has announced the acquisition of global rights to a clinical-stage Parkinson’s disease cell therapy,…
Read More
In an era increasingly shaped by artificial intelligence, the promise of rapidly scalable, AI-driven enterprises has captivated the global imagination.…
Read More
In an era increasingly shaped by the transformative power of artificial intelligence, a Los Angeles-based telehealth startup, MEDVi, has captured…
Read More
The pursuit of groundbreaking innovation in advanced therapeutic medicinal products (ATMPs) is a high-stakes endeavor, particularly for early-stage biotech startups…
Read More